Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTNK-tPA vs Alteplase in STEMI
NCT02835534Phase 4Completed
- Sponsor
- Recomgen Biotech
- Start
- May 2016
- Primary completion
- Oct 2019
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tenecteplase in ST elevation myocardial infarction (STEMI), sponsored by Recomgen Biotech. Started May 2016; status: completed.
02
Drugs
tenecteplase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02835534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02835534.